InsidersTradesSigma
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
5
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-12.3%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by BUCHI J KEVIN, Director. Insider active across 5 companies, notably Ziopharm Oncology INC. Aggregated, 21 filings have been logged. Breakdown: 5 buys · 0 sell. Total volume traded: €26k. History available since 4 March 2021. The latest transaction was filed on 12 March 2025 (Don). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations21 total
51,813 sharesCommon StockSEC:0001193125-26-290586:0
40,258 sharesClass A Common StockSEC:0001628280-25-024004:0
103,626 shares0Common StockSEC:0001062993-25-005393:0
262,072 shares0Class A Common StockSEC:0001628280-25-012344:0
51,813 shares@ US$3.86100.0% of flowCommon StockSEC:0001062993-25-004077:0
76,453 sharesClass A Common StockSEC:0001628280-24-023247:0
51,813 sharesCommon StockSEC:0000950170-23-042536:0
Ideal exit: 7 May 2024 (T+270)
21,858 shares@ US$0.287522.5% of flowCommon StockSEC:0001615594-23-000047:0
Ideal exit: 5 Mar 2024 (T+270)
25,000 shares@ US$0.29626.4% of flowCommon StockSEC:0001615594-23-000046:0
Ideal exit: 4 Mar 2024 (T+270)
32,534 shares@ US$0.274331.6% of flowCommon StockSEC:0001615594-23-000033:0
Ideal exit: 10 Feb 2024 (T+270)
23,440 shares@ US$0.235219.5% of flowCommon StockSEC:0001615594-23-000032:0
Ideal exit: 6 Feb 2024 (T+270)
80,128 sharesClass A Common StockSEC:0001209191-23-028734:0
35,406 sharesClass A Common StockSEC:0001209191-22-028155:0
4,666 shares@ US$38.2550.0% of flowCommon StockSEC:0001399529-21-000195
4,666 shares@ US$38.2550.0% of flowCommon StockSEC:0001399529-21-000195:0
4,666 sharesCommon StockSEC:0001399529-21-000106
4,666 sharesCommon StockSEC:0001399529-21-000106:0
46,218 sharesClass A Common StockSEC:0001209191-21-030806:0
46,218 sharesClass A Common StockSEC:0001209191-21-030806
4,167 shares0Common StockSEC:0001209191-21-030738:0
4,167 sharesCommon StockSEC:0001209191-21-030738
21 of 21 declarations
About BUCHI J KEVIN
Kevin J. Buchi is a Board Member at ZioPharm Oncology Inc, Amneal Pharmaceuticals, Inc., and Dicerna Pharmaceuticals Inc. With experience in the pharmaceutical sector, he contributes to the governance and strategy of the companies. His role is essential in guiding decisions that foster innovation and growth.
